Insider Cluster (2 insiders) ·Filed Aug 24, 2026

UTHR

UNITED THERAPEUTICS Corp
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago
Insider cluster: 2 insiders, $1.1M total
Actionable Insight • Neutral

The insider selling is trivial in proportion to UTHR's $22B market cap and is consistent with routine portfolio diversification or tax-related planning following option exercises. No bearish signal. Monitor for any material corporate events (earnings, pipeline updates) that could drive the stock, but this filing has no standalone trading implication.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
UTHR ▼ -3.56% at T+20d
NEUTRAL call ✗ call lost -3.56% · α vs SPY -3.57% · entry $512.88 → $494.63
Next anchor: T+60d in 6w
Latest observation: T+26 +9.40% FF3 residual α
Entry anchored
Aug 21, 04:53 PM ET
via 1-min bar
T+1d
+1.10%
call +1.10% · α +0.78%
$518.53
settled 6w ago
T+5d
-0.49%
call -0.49% · α -0.96%
$510.38
settled 5w ago
T+20d
-3.56%
call -3.56% · α -3.57%
$494.63
settled 11d ago
T+60d
—
call — · α —
—
in 6w

Price Chart

Loading chart...

Executive Summary

CEO Martine Rothblatt and EVP Paul Mahon sold a combined ~$1.1M in open-market sales over two days. The CEO's sales follow a derivative exercise and are part of a larger cluster of 20+ trades totaling ~$6.5M in gross proceeds, but the net economic value of open-market sales in this cluster is ~$1.1M, which is ~0.005% of UTHR's $22B market cap — trivial in proportion. The historical calibration shows past neutral reports on UTHR have had negative T+20 alpha, but the insider selling here is too small to be informative and is likely liquidity/plan-driven.

Key Financial Metrics

Direction
selling
Total Value
$1.1M
Insiders
2

Key Facts

  • CEO Martine Rothblatt sold ~$5.8M in open-market shares on Aug 21, 2026, following a derivative exercise of 9,500 shares at $135.42.
  • EVP & General Counsel Paul Mahon sold ~$508K in open-market shares on Aug 20, 2026.
  • Total open-market sales in the cluster are ~$1.1M, representing ~0.005% of UTHR's $22B market cap — trivial.
  • The CEO's sales are part of a larger pattern of 20+ trades in a 7-day window, but the dollar amount is immaterial relative to company size.
  • No insider buying was reported in the cluster.

Financial Impact

Total open-market insider sales of ~$1.1M, or ~0.005% of market cap — immaterial.

insider_ownership

Risk Factors

  • Insider selling could be misinterpreted as bearish by retail traders.
  • No material risk identified from this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (22 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-UTHR-1787642054476
91 reports for UTHR
Performance horizon
80% Hit rate 4 of 5 directional calls best @ T+60▲ +5.53%Feb 25, 2026
Filters
Rows
Reports for UTHR — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
Insider Cluster
NEUTRAL ★ 2/10
$500.35 $497.31▼ −0.61%▼ −2.72%$571.38 (+14.20%)
Sep 11, 2026
21d ago
Insider Cluster
NEUTRAL ★ 3/10
$497.11 $494.63▼ −0.50%▼ −0.28%$571.38 (+14.94%)
Sep 10, 2026
22d ago
Insider Cluster
MIXED ★ 4/10
$503.86 $497.27▼ −1.31%▼ −0.81%$571.38 (+13.40%)
Sep 9, 2026
23d ago
Insider Cluster
NEUTRAL ★ 3/10
$506.82 $498.48▼ −1.65%▼ −0.99%$571.38 (+12.74%)
Sep 4, 2026
28d ago
Insider Cluster
NEUTRAL ★ 2/10
$487.61 $502.70▲ +3.09%▲ +4.30%$571.38 (+17.18%)
Sep 3, 2026
29d ago
Insider Cluster
NEUTRAL ★ 2/10
$488.16 $497.11▲ +1.83%▲ +2.98%$571.38 (+17.05%)
Aug 28, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$515.46 $487.61▼ −5.40%▼ −5.51%$571.38 (+10.85%)
Aug 27, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$527.91 $492.02▼ −6.80%▼ −6.03%$571.38 (+8.23%)
Aug 26, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$516.68 $492.02▼ −4.77%▼ −4.65%$571.38 (+10.59%)
Aug 25, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$516.68 $492.02▼ −4.77%▼ −4.65%$571.38 (+10.59%)
Showing 10 of 91

US Market Status

Market Open — Closes in 6h 29m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 25, 2026